Exeter Combine Clinic will help producers maintain machines

Jun 15, 2018

Huron Tractor in Exeter is offering cash-croppers an opportunity to learn from a team of highly trained specialists.

Combine Clinics on June 20 and 21 will feature guest speaker Lois Sinclair, Regional Program Lead with Ontario Soil and Crop, discussing the Canadian Ag Partnership program.

Lunch will be provided along with special promotions on used John Deere combines, parts, special deals on Honda & Stihl equipment, and attendees are encouraged to enter a draw each day for a free Huron Tractor Combine Annual Service Inspection.

The agenda will include:

Settings, calibrations and adjustments
Key maintenance areas
John Deere integrated solutions updates
Crary air reels, wind systems, cutting systems

“We are passionate about providing our customers top quality equipment and service,” said Huron Tractor’s General Manager – Product Support, Leon Cormier yesterday.

“We go above and beyond to provide support beyond the sale and are excited to help our customers maintain their machines and stay informed of the latest agriculture trends and innovations.”

Registration is not required for the clinics, which run from 9:30 am to 2:30 pm on both days. For more information, visit www.hurontractor.com/2018-combineclinic or call 519-235-1115

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.